Stockscreener 앱 받기
40.77
2.41%
0.96
Maze Therapeutics Inc 주식(MAZE)의 최신 뉴스
Maze Therapeutics: An Innovative, Nature-Driven Platform (NASDAQ:MAZE) - Seeking Alpha
Assessing Maze Therapeutics (MAZE) Valuation After Its Recent Share Price Momentum - Sahm
What dividend safety score for Maze Therapeutics Inc. stockInflation Watch & Proven Capital Preservation Tips - Bộ Nội Vụ
Gainers Report: How Maze Therapeutics Inc stock valuations compare to rivals2025 Technical Patterns & AI Forecast for Swing Trade Picks - Bộ Nội Vụ
How Maze Therapeutics Inc. stock benefits from tech adoptionJuly 2025 Final Week & Risk Managed Investment Entry Signals - Улправда
How Maze Therapeutics Inc. stock valuations compare to rivalsStock Surge & Low Risk Profit Maximizing Plans - Улправда
Maze Therapeutics (NASDAQ:MAZE) CMO Sells 25,156 Shares - MarketBeat
Maze Therapeutics (MAZE) Stock Analysis: Exploring a 21.52% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Maze Therapeutics Director Makes Major Insider Move With High-Value Stock Sale - TipRanks
How rising interest rates impact Maze Therapeutics Inc. stock2025 Sector Review & Daily Momentum Trading Reports - Улправда
How Maze Therapeutics Inc. stock reacts to oil pricesJuly 2025 Technicals & Daily Oversold Stock Bounce Ideas - Улправда
Is Maze Therapeutics Inc. stock trading at a premium valuation2025 Bull vs Bear & Safe Capital Growth Stock Tips - Улправда
What sentiment indicators say about Maze Therapeutics Inc. stockQuarterly Profit Summary & Reliable Price Breakout Alerts - Улправда
Is Maze Therapeutics Inc. stock supported by innovation pipeline2025 Technical Patterns & Expert Approved Trade Ideas - Улправда
Harold Bernstein Sells 4,432 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock - MarketBeat
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
BERNSTEIN HAROLD Insider Trades - Nasdaq
Maze Therapeutics (NASDAQ:MAZE) Stock Price Down 4.9% – Here’s Why - Defense World
Aug Patterns: How Maze Therapeutics Inc stock compares to market leadersWeekly Trade Summary & Free High Accuracy Swing Entry Alerts - moha.gov.vn
Maze Therapeutics (NASDAQ:MAZE) Trading Down 4.9%Here's Why - MarketBeat
Amy Bachrodt Sells 5,000 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock - Defense World
Amy Bachrodt Sells 10,000 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock - Defense World
Harold Bernstein Sells 45,000 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock - Defense World
Atul Dandekar Sells 72,400 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock - Defense World
Maze Therapeutics SVP, finance sells $606k in shares By Investing.com - Investing.com Australia
Maze Therapeutics (NASDAQ:MAZE) CMO Sells $1,825,200.00 in Stock - MarketBeat
Insider Selling: Maze Therapeutics (NASDAQ:MAZE) SVP Sells 5,000 Shares of Stock - MarketBeat
Maze Therapeutics SVP, finance sells $606k in shares - Investing.com
Maze Therapeutics Insider Sold Shares Worth $1,825,355, According to a Recent SEC Filing - marketscreener.com
Maze Therapeutics Executives Engage in Significant Stock Transactions - TradingView — Track All Markets
Maze Therapeutics (NASDAQ:MAZE) Insider Sells $2,936,544.00 in Stock - MarketBeat
Maze Therapeutics, Inc. (NASDAQ:MAZE) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Growth Recap: Is Maze Therapeutics Inc stock trading at a premium valuationEarnings Overview Summary & Free Real-Time Volume Trigger Notifications - Bộ Nội Vụ
New way to pay for at‑home AI neurorehab aims to widen access - Stock Titan
We Think Maze Therapeutics (NASDAQ:MAZE) Can Easily Afford To Drive Business Growth - Yahoo Finance
FY2025 Earnings Estimate for MAZE Issued By Lifesci Capital - MarketBeat
Maze Therapeutics price target raised to $46 from $34 at Guggenheim - MSN
Maze Therapeutics (NASDAQ:MAZE) Stock Rating Upgraded by Lifesci Capital - Defense World
Guggenheim raises Maze Therapeutics stock price target to $46 on CKD program - Investing.com Canada
Lifesci Capital Upgrades Maze Therapeutics (NASDAQ:MAZE) to Strong-Buy - MarketBeat
Leerink Partners raises Maze Therapeutics stock price target to $50 on AMKD study - Investing.com Canada
Edison Issues Report on MindMaze Therapeutics (MMTX) - TMX Newsfile
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics - Yahoo Finance
Frazier Life Sciences Management L.P. Buys 438,274 Shares of Maze Therapeutics, Inc. $MAZE - MarketBeat
Maze Therapeutics (NASDAQ:MAZE) Upgraded at Wall Street Zen - MarketBeat
Maze Therapeutics (NASDAQ:MAZE) Stock Price Down 6.2%Time to Sell? - MarketBeat
CW Advisors LLC Purchases Shares of 30,235 Maze Therapeutics, Inc. $MAZE - MarketBeat
Investment Report: How Maze Therapeutics Inc stock benefits from tech adoptionJuly 2025 Market Mood & Accurate Buy Signal Alerts - BỘ NỘI VỤ
Maze Therapeutics (MAZE) Price Target Increased by 11.37% to 44.12 - Nasdaq
4.73%
0.92%
자본화:
|
볼륨(24시간):